XML 22 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share-Based Compensation
9 Months Ended
Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation
Share-Based Compensation

Employee Share-Based Compensation Plans - On May 29, 2008, the Company's shareholders approved the 2008 Omnibus Employee Incentive Plan (the "2008 Plan") providing for the grant of stock options, stock appreciation rights, non-vested stock, and performance shares. There were no options for the purchase of shares granted under the 2008 Plan during the three month periods ended September 30, 2016 and 2015. During the nine month periods ended September 30, 2016 and 2015, the Company granted 153,332 and 40,000 options, respectively, for the purchase of shares under the 2008 Plan. As of September 30, 2016, 42,124 shares remain available for grant under the 2008 Plan.
    
On May 24, 2011, the Company's shareholders approved the 2011 Omnibus Employee Incentive Plan, as subsequently amended and restated, (the "2011 Plan") providing for the grant of stock options and non-vested stock awards. During the three and nine month periods ended September 30, 2016, there were no options for the purchase of shares granted under the 2011 Plan. During the three and nine month periods ended September 30, 2015, there were 16,667 and 46,667 options, respectively, for the purchase of shares granted under the 2011 Plan. There were no stock awards granted under the 2011 Plan during the three month period ended September 30, 2016. During the nine month period ended September 30, 2016, the Company granted a total of 166,665 stock awards under the 2011 Plan to non-employee members of the Board of Directors that immediately vested. During the three and nine month periods ended September 30, 2015, the Company granted 33,333 and 36,111 stock awards, respectively, under the 2011 Plan to non-employee members of the Board of Directors that immediately vested. As of September 30, 2016, 243,693 shares remain available for grant under the 2011 Plan.

There were no options granted during three month period ended September 30, 2016. The fair value of the stock options granted during the nine month period ended September 30, 2016, were estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:

 
Nine Months Ended September 30,
 
2016
Expected life (years)
5.1
Expected volatility
81.0%
Expected dividend yield
—%
Risk-free interest rate
1.4%
Weighted average fair value of options granted during the period
$1.33


The following table summarizes stock option activity for the nine month period ended September 30, 2016:
 
 
Number of Options
 
Weighted Average Exercise Price Per Option
 
Weighted Average remaining Contractual Life (years)
 
Aggregate Intrinsic Value (in thousands)
Outstanding balance at December 31, 2015
 
286,568

 
$
6.46

 
 
 
 
Granted
 
153,332

 
2.05

 
 
 
 
Exercised
 

 

 
 
 
 
Forfeited and Expired
 
(46,690
)
 
5.43

 
 
 
 
Outstanding balance at September 30, 2016
 
393,210

 
4.87

 
8.23
 
$0
Options exercisable at September 30, 2016
 
177,807

 
$
7.15

 
7.07
 
$0


There were no options exercised during the nine month period ended September 30, 2016. There were 3,333 options with a weighted average exercise price of $6.75 exercised during the nine month period ended September 30, 2015. Options for the purchase of an aggregate of 66,668 shares of common stock vested during the nine month period ended September 30, 2016, and the aggregate fair value at grant date of these options was $0.3 million. As of September 30, 2016, there was approximately $0.2 million of total unrecognized compensation cost related to stock options. The cost is expected to be recognized over a weighted average period of 1.93 years.
The Company recorded $0.1 million and $0.5 million, respectively, of share-based compensation expense in selling, general, and administrative expenses for the three and nine month periods ended September 30, 2016. The Company recorded $0.2 million and $0.4 million, respectively, of share-based compensation expense in selling, general and administrative expenses for the three and nine month periods ended September 30, 2015.